CD4 and neoplasm: The CD8+ T and CD4+ T cells are the most abundant types of T lymphocytes in tumor microenvironments and capable of eliminating tumor cells, their differentiation into dysfunctional states may render them ineffective at responding to immunotherapy [85,86].